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Abstract
Objective: Infective necrotizing pancreatitis is widely accepted as a sur-
gical disease, but the appropriate timing of surgical intervention is con-
troversial. Some authors prefer early surgery, while most consensus and 
guidelines agree that late surgery has more benefit. We reviewed our insti-
tutional experience in the surgical management of necrotizing pancreatitis, 
focusing on the results of early and late surgical intervention.
Materials and Methods: Data for patients with necrotizing pancreatitis 
who underwent surgical intervention between July 1996 and June 2004 
were analyzed. According to the timing of surgical intervention, they were 
subdivided into the early group (≤ 14 days after disease onset, 7 patients) 
and late group (> 14 days after disease onset, 11 patients).
Results: Patients in the early surgery group had more operations (mean, 
3.86 vs. 1.36; p = 0.0342) and a higher mortality rate (42.8% vs. 0%; 
p = 0.043) compared to the late surgery group.
Conclusion: Our experience was that late surgery for necrotizing pancre-
atitis can lead to a lower mortality rate and is more beneficial to patients, 
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According to the Atlanta consensus in 1993, acute 
pancreatitis can be allocated into the mild or severe 
type [1]. Eighty percent of patients have mild acute 
pancreatitis and this type is less complicated. Con-
versely, severe acute pancreatitis (in about 10–25% 
of patients) is a relatively more fatal form, with a 
mortality of approximately 30–40% [2,3]. Surgeons 
need to consider candidates who may need surgical 
intervention. Most consensus and published guide-
lines agree that sterile necrotizing pancreatitis should 
be managed conservatively and surgical treatment 
should be preserved for infective cases [4,5]. How-
ever, the timing of surgery for necrotizing pancreati-
tis remains controversial [6]. In this retrospective study, 
we reviewed our experience of the surgical treatment 
of necrotizing pancreatitis in a small medical center in 
eastern Taiwan, with a focus on the most appropriate 
timing of intervention.
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2. Materials and methods
The records of consecutive patients with a diagnosis 
of acute pancreatitis admitted to Buddhist Tzu Chi 
General Hospital from July 1996 to June 2004 were 
obtained from the computerized database of the 
hospital. The search was according to the Interna-
tional Classification of Diseases-9 (ICD-9) code for 
acute pancreatitis (code 577.0).
From the resultant cohort, subsequent restriction 
focused on patients who underwent surgical debride-
ment, necrosectomy or pancreatectomy. Their medi-
cal records were reviewed, and those whose diagnosis 
was not necrotizing pancreatitis were excluded. The 
diagnosis of necrotizing pancreatitis was based on 
pre operative abdominal computed tomography (CT) 
features (a non-enhanced pancreatic parenchyma of 
more than 3 cm or more than 30% of the parenchyma 
in an enhanced CT scan) or intraoperative findings. 
The etiology of acute pancreatitis was defined in each 
patient. These patients were further subdivided into 
two groups: those who received their first surgical in-
tervention ≤  14 days after disease onset (early group), 
and those who underwent surgical intervention > 14 
days (late group) after disease onset. The decision to 
proceed to surgical exploration was judged by the in-
dividual attending surgeon, basically according to 
bact eriological results of fine-needle aspiration (FNA) 
or deterioration of the clinical course in spite of ag-
gressive intensive care. The following variables were 
obtained in each group: age, gender, Ranson score, 
preoperative organ failure status, number of opera-
tions, and morbidity and mortality rate. The length 
of hospital stay (LOS) was determined in patients 
who survived. We then compared survivors and non-
survivors with the same variables in the early and 
late groups.
Statistical analysis of variables between the early 
and late groups was made using Student’s unpaired 
t test and Fisher’s exact test when appropriate. 
Probabilities ≤ 0.05 were considered significant.
3. Results
Overall, there were 329 patients with a diagnosis of 
acute pancreatitis identified from July 1996 to June 
2004, with a total of 18 patients who underwent sur-
gical intervention (surgical debridement, necrosec-
tomy or pancreatectomy) for necrotizing pancreatitis, 
which accounted for 5.4% of this cohort. The mean 
age of the patients was 36.38 years (range, 20–72 
years), and the male-to-female ratio was 5:1. The eti-
ologies of acute pancreatitis were alcohol-related in 
seven patients (38.9%), hyperlipidemia in three pa-
tients (16.7%), both alcohol-related and hyperlip-
idemia in five patients (27.8%), post-traumatic in two 
patients (11.1%), and biliary in one patient (5.5%) 
(Table 1). Surgery was performed in 16 of the 18 
patients because they were considered infective ac-
cording to the results of FNA. In the remaining two 
patients, one had surgery due to persistent fever al-
though the FNA culture was negative. The other pa-
tient had hemoperitoneum and was in a state of 
shock. The preoperative microbiological results of 
those who received FNA preoperatively showed that 
12 patients had polymicrobial (75%) infection and 
four patients had monomicrobial (25%) infection. 
Escherichia coli was cultured in four patients, and it 
was cultured most frequently. The morbidity rate for 
all patients was 83.3% (15 of 18 patients), and the 
mortality rate was 16.7% (3 of 18 patients). The 
most common complication was wound infection 
(Table 2).
Table 1 — Comparison of early and late groups*
 Early Late p
Number of patients 7 11
Gender (male/female) 7/0 8/3 0.245
Age (yr) 42.1 (30–72) 32.7 (20–46) 0.089
Etiology
 Alcohol-related 2 5
 Hyperlipidemia 0 3
 Both alcohol-related and hyperlipidemic 3 2
 Post-traumatic 2 0
 Biliary 0 1
Ranson score 4 (1–6) 3.1 (0–5) 0.299
Number of operations 3.86 (1–11) 1.36 (1–3) 0.034†
Preoperative organ failure‡ 4 (57.1%) 3 (27.3%) 0.335
Hospital stay (survivors) 68.75 (31–112) 80.5 (29–155) 0.614
Morbidity 6 (85.7%) 7 (67.3%) 1.000
Mortality 3 (42.8%) 0 0.043†
*Data presented as n, mean (range), or n (%); †p < 0.05; ‡number of patients who developed organ failure preoperatively.
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There were seven and 11 patients in the early and 
late groups, respectively. Patient data are shown in 
Table 1. The differences in age, gender, Ranson score, 
preoperative organ failure, LOS and morbidity were 
not significant. However, the mean number of opera-
tions (3.86 vs. 1.36) and the mortality rate (42.8% 
vs. 0%) were all significantly higher in the early group 
(p = 0.034 and p = 0.043, respectively) (Table 1).
4. Discussion
Acute pancreatitis is a medical disease most of the 
time, and it usually resolves uneventfully. Most deaths 
occur in patients with severe acute pancreatitis, which 
is usually a clinical manifestation of pancreatic necro-
sis [1]. The clinical course of severe acute pancreati-
tis can be divided into two phases. The first phase 
encompasses the first 2 weeks and has the features 
of systemic inflammatory response syndrome (SIRS). 
The release of proinflammatory mediators contributes 
to the pathogenesis of SIRS-associated pulmonary, 
cardiovascular, and renal insufficiency. The second 
phase is accompanied by local or systemic infectious 
complications, and the incidence of infection in pan-
creatic necrosis is about 30–70% [5,7]. This distinc-
tion also explains the differences in causes of death 
as time progresses, that is, multiorgan failure due to 
SIRS in the early stage and sepsis in the late stage.
There is not much debate concerning conserva-
tive treatment with aggressive intensive care as long 
as the necrosis is sterile. Surgical intervention should 
be undertaken when infective necrosis is confirmed 
[2–5,7–16], although some reports on nonoperative 
management of infective necrotizing pancreatitis 
have been published recently [17,18]. Other indica-
tions for surgical treatment include intestinal infarc-
tion or perforation, exsanguinating hemorrhage, and 
abdominal compartment syndrome [2,19–23].
The most conflicted issue is the timing of surgical 
intervention for infective necrotizing pancreatitis. This 
can be classified into early or late intervention. The 
rationale for early intervention is that infected necro-
sis tends to have a greater extent of necrosis, a greater 
number of organ failures and an increased mortality 
rate. Surgical or radiologic intervention that provides 
adequate debridement or drainage to control the 
necrosis can eradicate the cause of organ failures. Fai-
lure to do so may result in 100% mortality. Those who 
support late intervention claim that the demarcation 
of viable and nonviable tissue is clearer in the late 
stage and can lead to less trauma to normal pancreatic 
tissue and decrease surgical mortality. The amount of 
remaining pancreatic parenchyma strongly influences 
the quality of long-term results with regard to endo- 
and exocrine pancreatic function [24]. Furthermore, 
most patients respond to intensive care treatment and 
surgery can be avoided [3,5,6].
There is no clear definition of what constitutes early 
and late intervention. In the series published, the def-
inition of early intervention was as short as 3 days 
and as long as 14 days (Table 3). The results of pub-
lished series are not identical. Three series concluded 
that late surgery decreased mortality [25–27], while 
another three series concluded that mortality was 
not statistically different between early and late sur-
gery, although it was actually higher in the early sur-
gery group [28–30]. In a prospective, randomized 
study, Mier et al compared patients who underwent 
their first operation within 48–72 hours of onset with 
those who had surgery at least 12 days later. Although 
the difference in mortality rate (58% in the early group 
vs. 27% in the late group) did not reach statistical 
significance, the odds ratio for mortality was 3.4 times 
Table 2 — Postoperative complications
 Early (n) Late (n) Total (n)
Wound infection 3 5 8
Sepsis 4 1 5
Residual abscess 1 3 4
Colon perforation 3 1 4
Enterocutaneous fistula 0 3 3
Acute renal failure 1 0 1
Acute respiratory 1 0 1
 distress syndrome
Splenic pseudoaneurysm 1 0 1
Ventral hernia 1 0 1
Choledochocutaneous 1 0 1
 fistula
Pancreatic fistula 1 0 1
Table 3 — Published series on surgical timing for necrotizing pancreatitis
Authors (year) [Ref.] Patients (early/late) Timing (early/late) Mortality (early/late)  Significance
Mier et al (1997) [28] 25/11 < 3 d/> 12 d 56%/27% No
Takeda et al (1998) [29] 110/69 ≤ 14 d/> 14 d 27.3%/27.5% No
Hungness et al (2002) [30] 14/11 ≤ 14 d/> 14 d 29%/18% No
Yang et al (2002) [26] 16/38 < 3 d/> 3 d 37.5%/10.5% Yes
Hartwig et al (2002) [25] 30/32 < 3 d/> 3 d 53%/22% Yes
Besselink et al (2007) [27] 16/11 ≤ 14 d/15–29 d  75%/45% Yes
 26 > 30 d 8%
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higher in the early group, which led them to stop the 
study due to the high mortality in the early surgery 
group [28]. In another retrospective review, Hung ness 
et al found that patients debrided early had a trend to-
ward higher mortality (29% vs. 18%) and experienced 
a higher number of major complications (p < 0.05) 
[30]. Takeda et al found that there was no difference 
in mortality between patients who had early surgery 
(≤ 14 days) and those who had late surgery (> 14 days) 
(27.3% vs. 27.5%) [29]. In a recent retrospective study, 
Besselink et al demonstrated that the mortality was 
even lower when surgery was performed after 30 days 
(8% vs. 75% in the 1–14-day group and 45% in the 
15–29-day group; p < 0.001) [27]. We used 14 days 
as a cut-off according to International Associ ation of 
Pancreatology guidelines [5]. In our study, patients in 
the late surgery group had fewer operations and a 
lower mortality rate compared to those in the early 
surgery group (p = 0.034 and p = 0.043, respectively).
One of the reasons for the high mortality in surgi-
cal patients with necrotizing pancreatitis is that sur-
gery results in major trauma to patients. In this era 
of minimally invasive surgery, this impact may be de-
creased. There are some data concerning this tech-
nique, but it has not yet been accepted as standard 
procedure [6,31–33].
In conclusion, we found that surgery more than 14 
days after disease onset can result in decreased mor-
tality compared to surgery before 14 days. This result 
coincides with most consensus and guidelines.
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